Charuwan Akewanlop , MD.

Dr. Charuwan Akewanlop’s Story

Dr. Charuwan Akewanlop graduated from Faculty of Medicine Siriraj Hospital. She then completed her postgraduate training in Internal Medicine Residency and Medical Oncology Fellowship from The United States. She has served as a faculty member at the Division of Medical Oncology, Faculty of Medicine Siriraj Hospital since 1999. Dr. Akewanlop is now the head of the Division of Medical Onoology at the Faculty of Medicine Siriraj Hospital. She has participated in several multicenter, international, randomized phase III clinical trials as the principal investigator or sub-investigator.

Research Interest

Breast cancer, colorectal cancer, lung cancer, head and neck cancer, sarcoma, palliative and supportive care

Department

Division of Medical Oncology, Department of Medicine

Professional Experience

2018-present	Vice president, Thai Society of Clinical Oncology (TSCO)
2017-present	Chief, Division of Medical Oncology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University

Specialized field

Medical oncology

 

研究実績

Low Fat-Free Mass Index Measured by Bioelectrical Impedance Analysis Correlates With Hematologic Adverse Events in Early-Stage Breast Cancer Patients Receiving Chemotherapy: A Prospective Observational Cohort Study

Jirawat Thanestada, Varalak Srinonprasert, Akarin Nimmannit, Krittiya Korphaisarn, Pornpoj Pramyothin, Charuwan Akewanlop

• 論文

Health-Related Quality of Life Outcomes in Patients with Resected Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer Who Received Adjuvant Osimertinib in the Phase III ADAURA Trial

Margarita Majem, Jonathan W Goldman, Thomas John, Christian Grohe, Konstantin Laktionov, Sang-We Kim, Terufumi Kato, Huu Vinh Vu, Shun Lu, Shanqing Li, Kye Young Lee, Charuwan Akewanlop, Chong-Jen Yu, Filippo de Marinis, Laura Bonanno, Manuel Domine, Frances A Shepherd, Shinji Atagi, Lingmin Zeng, Yi-Long Wu

• 論文

Postoperative Chemotherapy Use and Outcomes From ADAURA: Osimertinib as Adjuvant Therapy for Resected EGFR-Mutated NSCLC

Yi-Long Wu, Thomas John, Christian Grohe, Margarita Majem, Jonathan W Goldman, Sang-We Kim, Terufumi Kato, Konstantin Laktionov, Huu Vinh Vu, Zhijie Wang, Shun Lu, Kye Young Lee, Charuwan Akewanlop, Chong-Jen Yu, Filippo de Marinis, Laura Bonanno, Manuel Domine, Frances A Shepherd, Lingmin Zeng, Ajlan Atasoy, et al.

• 論文

Correlation between week 24 trastuzumab-dkst response and week 48 progression-free survival: the HERITAGE trial

Hope S Rugo, Eduardo J Pennella, Unmesh Gopalakrishnan, Miguel Hernandez-Bronchud, Jay Herson, Hans Friedrich Koch, Subramanian Loganathan, Sarika Deodhar, Ashwani Marwah, Alexey Manikhas, Igor Bondarenko, Joseph D Parra, Maria Luisa T Abesamis-Tiambeng, Charuwan Akewanlop, Ihor Vynnychenko, Virote Sriuranpong, Sirshendu Roy, Eduardo Patricio Yanez Ruiz, Abhijit Barve, Cornelius F Waller

• 論文

Final overall survival analysis of the phase 3 HERITAGE study demonstrates equivalence of trastuzumab-dkst to trastuzumab in HER2-positive metastatic breast cancer

Hope S Rugo, Eduardo J Pennella, Unmesh Gopalakrishnan, Miguel Hernandez-Bronchud, Jay Herson, Hans Friedrich Koch, Subramanian Loganathan, Sarika Deodhar, Ashwani Marwah, Alexey Manikhas, Igor Bondarenko, Guzel Mukhametshina, Gia Nemsadze, Joseph D Parra, Maria Luisa T Abesamis-Tiambeng, Kakhaber Baramidze, Charuwan Akewanlop, Ihor Vynnychenko, Virote Sriuranpong, Cornelius F Waller, et al.

• 論文

Osimertinib in Resected EGFR-Mutated Non-Small-Cell Lung Cancer

Yi-Long Wu, Masahiro Tsuboi, Jie He, Thomas John, Christian Grohe, Margarita Majem, Jonathan W Goldman, Konstantin Laktionov, Sang-We Kim, Terufumi Kato, Huu-Vinh Vu, Shun Lu, Kye-Young Lee, Charuwan Akewanlop, Chong-Jen Yu, Filippo de Marinis, Laura Bonanno, Manuel Domine, Frances A Shepherd, Lingmin Zeng, et al.

• 論文

Impact of Obesity on Outcomes of Operable Breast Cancer: A Retrospective Cohort Study

Tanapat Engkakul, Nuntakorn Thnogtang, Akarin Nimmannit, Suebwong Chuthapisith, Charuwan Akewanlop

• 論文

Effect of a Proposed Trastuzumab Biosimilar Compared With Trastuzumab on Overall Response Rate in Patients With ERBB2 (HER2)-Positive Metastatic Breast Cancer: A Randomized Clinical Trial

Hope S Rugo, Abhijit Barve, Cornelius F Waller, Miguel Hernandez-Bronchud, Jay Herson, Jinyu Yuan, Rajiv Sharma, Mark Baczkowski, Mudgal Kothekar, Subramanian Loganathan, Alexey Manikhas, Igor Bondarenko, Guzel Mukhametshina, Gia Nemsadze, Joseph D Parra, Maria Luisa T Abesamis-Tiambeng, Kakhaber Baramidze, Charuwan Akewanlop, Ihor Vynnychenko, Virote Sriuranpong, et al.

• 論文

Deficient DNA mismatch repair is associated with favorable prognosis in Thai patients with sporadic colorectal cancer

Krittiya Korphaisarn, Ananya Pongpaibul, Chanin Limwongse, Ekkapong Roothumnong, Wipawi Klaisuban, Akarin Nimmannit, Artit Jinawath, Charuwan Akewanlop

• 論文

Phagocytosis of breast cancer cells mediated by anti-MUC-1 monoclonal antibody, DF3, and its bispecific antibody

C Akewanlop, M Watanabe, B Singh, M Walker, D W Kufe, D F Hayes

• 論文